123 related articles for article (PubMed ID: 14676785)
1. In vitro monitoring of endothelial complications following hematopoietic allogeneic stem cell transplantation.
Ganster A; Brucker I; Holler E; Hahn J; Bremm H; Andreesen R; Eissner G
Bone Marrow Transplant; 2004 Feb; 33(3):355-7. PubMed ID: 14676785
[No Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.
Nachbaur D; Schumacher P; Auberger J; Clausen J; Kircher B
Biol Blood Marrow Transplant; 2007 Aug; 13(8):942-7. PubMed ID: 17640598
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelium as 'novel' target of graft-versus-host disease.
Tichelli A; Gratwohl A
Best Pract Res Clin Haematol; 2008 Jun; 21(2):139-48. PubMed ID: 18503982
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelium and graft-versus-host disease.
Biedermann BC
Best Pract Res Clin Haematol; 2008 Jun; 21(2):129-38. PubMed ID: 18503981
[TBL] [Abstract][Full Text] [Related]
5. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.
Cooke KR; Jannin A; Ho V
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):23-32. PubMed ID: 18162218
[TBL] [Abstract][Full Text] [Related]
6. Deep lamellar keratoplasty for corneal perforation due to chronic graft-versus-host disease following allogeneic hematopoietic stem-cell transplantation.
Yuta K; Kami M; Matsumoto Y; Murashige N; Suzuki S
Haematologica; 2005 Mar; 90(3):ECR15. PubMed ID: 15753056
[No Abstract] [Full Text] [Related]
7. The role of innate immunity in graft-versus-host disease and complications following allogeneic stem cell transplant.
Holler E
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):59-61. PubMed ID: 19147080
[No Abstract] [Full Text] [Related]
8. Alveolar hemorrhage and acute graft-versus-host disease.
Ratajczak P; Desveaux A; Socié G; Janin A
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1244-5. PubMed ID: 17889362
[No Abstract] [Full Text] [Related]
9. Jaundice after allogeneic hematopoietic stem cell transplantation.
Mendizabal M; Chen T; Reddy KR
Hepatology; 2009 Dec; 50(6):2044-5. PubMed ID: 19937681
[No Abstract] [Full Text] [Related]
10. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Remberger M
Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922
[No Abstract] [Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation.
Deconinck E; Kribs M; Rebibou JM; Bulabois CE; Ducloux D; Cahn JY
Haematologica; 2005 Apr; 90(4):569-70. PubMed ID: 15820963
[TBL] [Abstract][Full Text] [Related]
13. Management of infections complicating allogeneic hematopoietic stem cell transplantation.
Hiemenz JW
Semin Hematol; 2009 Jul; 46(3):289-312. PubMed ID: 19549581
[TBL] [Abstract][Full Text] [Related]
14. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Escolar G; Eissner G; Holler E; Carreras E
Biol Blood Marrow Transplant; 2009 May; 15(5):537-46. PubMed ID: 19361745
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.
Pihusch V; Rank A; Steber R; Pihusch M; Pihusch R; Toth B; Hiller E; Kolb HJ
Transplantation; 2006 May; 81(10):1405-9. PubMed ID: 16732177
[TBL] [Abstract][Full Text] [Related]
16. Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature.
Padmanabhan S; Battiwalla M; Hahn T; Ball D; Paplham P; Brown K; Segal BH; McCarthy P; Almyroudis NG
Transpl Infect Dis; 2007 Jun; 9(2):148-52. PubMed ID: 17462002
[TBL] [Abstract][Full Text] [Related]
17. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.
Woywodt A; Haubitz M; Buchholz S; Hertenstein B
Bone Marrow Transplant; 2004 Dec; 34(12):1015-23. PubMed ID: 15516935
[TBL] [Abstract][Full Text] [Related]
18. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
[TBL] [Abstract][Full Text] [Related]
20. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
